The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension...
Date First Received: April 10, 2006
Last Updated: December 19, 2007
Verified by: Alcon Research, December 2007
Clinical Trial Phase: Phase 3 | Start Date: November 2005
Overall Status: Completed
Estimated Enrollment: 430
Brief Summary
Official Title: “A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension”
Condition Keyword(s):
Intervention(s):
The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Intervention(s) in this Clinical Trial
- Drug: Brinzolamide/Timolol
Outcome Measures for this Clinical Trial
Primary Measures
- Mean IOP
Secondary Measures
- Percent patients with IOP < 18 mmHg
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Either sex
Exclusion Criteria:
- under 18
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Alcon Research
Overall Clinical Trial Officials and Contacts
Terry Wiernas, PhD Study Director Study Director
Additional Information
Information obtained from ClinicalTrials.gov on September 05, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00314171
Study ID Number: C-05-10
ClinicalTrials.gov Identifier: NCT00314171
Health Authority: United States: Food and Drug Administration
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
